Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing.

Anais brasileiros de dermatologia - 1 Jan 2000

Huang Ting, Ding Ting, Ding Liqing, Xie Shasha, Li Xiaojing, Meng Qiming, Wu Xiaomeng, Luo Hui, Zhao Hongjun

Abstract excerpt

BACKGROUND: Dermatomyositis (DM) is an infrequent disease subgroup of idiopathic inflammatory myopathies characterized by distinct skin lesions. However, high heterogeneity makes clinical diagnosis and treatment of DM very challenging. OBJECTIVES: Unsupervised classification in DM patients and analysis of key factors related to clinical outcomes. METHODS: This retrospective study was conducted between 2017 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Cluster Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dermatomyositis

Share to Interferon-Induced Helicase, IFIH1

Share to Lung Diseases, Interstitial

Share to Outcome Assessment, Health Care

Share to Serologic Tests

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 38522973
DOI: 10.1016/j.abd.2023.06.005
PMCID: PMC11074555

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing.PMID 38522973Read ↗

Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.Semantic proximity Read ↗

Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Site-level cutaneous phenotyping framework for anti-MDA5-positive dermatomyositis: exploratory associations with systemic immune reference markers.Semantic proximity Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity Read ↗

From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis.Semantic proximity Read ↗

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.Semantic proximity Read ↗

Cluster analysis of clinical phenotypes in idiopathic inflammatory myopathy patients complicated with cardiac involvement.Semantic proximity Read ↗

Integrated multi-dimensional analyses reveal a BTN3A2-centered diagnostic risk score and a monocyte-T cell axis as central drivers of dermatomyositis.Semantic proximity Read ↗

Characterization of necroptosis and immune landscape in dermatomyositis by bioinformatics analysis and machine learningSemantic proximity Read ↗

Analysis of the Potential Link Between Dermatomyositis and CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.